Shipped on ice packs. Upon receipt, store the product at the temperature recommended below.
Store the complete kit at 2 – 8 °C. Under these conditions, all components are stable until the expiration date (see label on the box).
0 - 16 - 64 µgEq/mL
Limit of Detection
CV ≤ 6.1%
CV ≤ 13.0%
94 - 105%
European Union: for in vitro diagnostic use
Rest of the world: for research use only!
The total assay time is less than 1.5 hours
Quantitative determination of CIC C3d concentration in human serum or
Assay format is 96 wells
Quality Controls (positive and negative) are ready to use
Standards are ready to use
For routine analysis
Immune Response, Infection and Inflammation
The complement system might play a role in many diseases with an immune component, such as Barraquer-Simons Syndrome Alzheimer's disease, asthma, lupus erythematosus, various forms of arthritis, autoimmune heart disease and multiple sclerosis. Deficiencies of the terminal pathway predispose to both autoimmune disease and infections (particularly meningitis). C3d binds covalently to erythrocytes (E-C3d) to form a stable long-lived cell-bound marker. Cross-sectional and longitudinal studies have found that measurement of these cell-bound complement activation products is useful in monitoring disease activity.